The Glycomic Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Glycomic Therapeutics Market?
The market size of glycomic therapeutics has seen swift expansion in the past few years. The market is expected to increase from $164.71 billion in 2024 and reach $190.03 billion in 2025, with a 15.4% compound annual growth rate (CAGR).
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Glycomic Therapeutics Industry?
The Glycomic Therapeutics Global Market is projected to increase to a value of $361.09 billion by 2029. This represents a compound annual growth rate (CAGR) of 17.4% over the forecast period.
Download Your Free Sample of the 2025 Glycomic Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Glycomic Therapeutics Market?
The key drivers in the glycomic therapeutics market are:
• Expanding knowledge of glycan biology
• The rise of precision medicine approaches
• Rising interest in immunotherapy
• Increased funding for rare diseases research and emergence of glycan biomarkers.
Global Market Segmentation: Identifying Major Glycomic Therapeutics Industry Segments
The glycomic therapeutics market covered in this report is segmented –
1) By Class: Isolated, Synthetic
2) By Structures: Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans, Targeting Glycosphingolipids, Other Structures
3) By Mode Of Action: Inhibits Neuraminidase, Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate, Erythropoietin And Enzyme Replacement Therapy (ERT), Tissue Plasminogen Activator, Inhibits Glucosylceramide Synthase, Interleukin 1, 2 And 3, Beta And Gamma Interferons, Other Mode Of Action
4) By Indications: Thrombosis And Chemoprophylaxis, Anemia, Anti-Adhesive And Anti-Inflammatory, Cataracts, Gaucher’s Disease, Mps-1 And IV, Cancer, Alzheimer’s Disease, Influenza Type A And B, Other Indications
Pre-order the 2025 Glycomic Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Glycomic Therapeutics Market?
The key trends in the glycomic therapeutics market are:
• Expansion of glycomic applications in the field of oncology is an emerging trend.
• Glycoengineering for enhanced therapeutic proteins is becoming increasingly significant.
• The inclusion of glycomics in immuno-oncology highlights an important trend.
• The use of glycomics in the treatment of rare and genetic disorders is a rising trend.
Who Are the Top Competitors & Leading Players in the Glycomic Therapeutics Market?
The major players in the glycomic therapeutics market are:
• F Hoffmann La Roche Ltd
Regional Dominance: Which Area Leads the Global Glycomic Therapeutics Market?
North America was the largest region in the glycomic therapeutics in 2024
